218 related articles for article (PubMed ID: 26429958)
1. 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.
Zheng K; Liang N; Zhang J; Lang L; Zhang W; Li S; Zhao J; Niu G; Li F; Zhu Z; Chen X
J Nucl Med; 2015 Dec; 56(12):1823-7. PubMed ID: 26429958
[TBL] [Abstract][Full Text] [Related]
2. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
Cheng W; Wu Z; Liang S; Fu H; Wu S; Tang Y; Ye Z; Wang H
PLoS One; 2014; 9(6):e100521. PubMed ID: 24956393
[TBL] [Abstract][Full Text] [Related]
4. A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.
Gao S; Wu H; Li W; Zhao S; Teng X; Lu H; Hu X; Wang S; Yu J; Yuan S
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2029-37. PubMed ID: 26153145
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of
Xie F; Zheng K; Liu L; Jin X; Fu L; Zhu Z
Front Oncol; 2022; 12():877501. PubMed ID: 35720018
[TBL] [Abstract][Full Text] [Related]
6. (68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
Li D; Zhao X; Zhang L; Li F; Ji N; Gao Z; Wang J; Kang P; Liu Z; Shi J; Chen X; Zhu Z
Mol Pharm; 2014 Nov; 11(11):3923-9. PubMed ID: 25093246
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
9. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
10. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Lu P; Sun Y; Sun Y; Yu L
Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model.
Guo N; Lang L; Li W; Kiesewetter DO; Gao H; Niu G; Xie Q; Chen X
PLoS One; 2012; 7(5):e37506. PubMed ID: 22624041
[TBL] [Abstract][Full Text] [Related]
12. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
[TBL] [Abstract][Full Text] [Related]
13. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
[TBL] [Abstract][Full Text] [Related]
14. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
[TBL] [Abstract][Full Text] [Related]
15. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
[TBL] [Abstract][Full Text] [Related]
17. Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke.
Sun Y; Zeng Y; Zhu Y; Feng F; Xu W; Wu C; Xing B; Zhang W; Wu P; Cui L; Wang R; Li F; Chen X; Zhu Z
Theranostics; 2014; 4(8):778-86. PubMed ID: 24955139
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Dual-Timepoint
Collarino A; Garganese G; Valdés Olmos RA; Stefanelli A; Perotti G; Mirk P; Fragomeni SM; Ieria FP; Scambia G; Giordano A; Rufini V
J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]